Following a warning from the U.S. Food and Drug Administration (FDA) regarding Tussionex cough syrup on March 11th, information regarding the safe administration of the prescription drug has been released.The FDA recommends that no child under the age of 6 should be prescribed Tussionex under any circumstance.
The cough syrup should only be taken in 12 hour increments. Overdose may result from taking Tussionex in increments more frequent than the recommended doses.
Symptoms of a Tussionex overdose include:
o Trouble breathing, including slow or shallow breathing
o Slow heart rate
o Sleepiness
o Cold, clammy skin
o Trouble walking or talking
o Feeling faint, dizzy or confused
Serious illness and death have been reported in connection with Tussionex.
Defective drug attorneys are currently working on cases involving the mislabeling of prescription drug products.
This entry was posted
on Friday, March 28th, 2008 at 8:11 pm and is filed under Defective Drugs, Recall, Safety, Trasylol, Tussinex.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
